Skip to main content
Log in

Effectiveness of thymectomy in non-thymomatous myasthenia gravis: a systematic review

  • Published:
Journal of Huazhong University of Science and Technology [Medical Sciences] Aims and scope Submit manuscript

Summary

There is continuous debate regarding the effectiveness of thymectomy in the treatment of non-thymomatous myasthenia gravis (MG). This systematic review was undertaken to determine whether thymectomy was effective in non-thymomatous MG. We retrieved articles published between January 1980 and September 2013. Sixteen cohort studies were included. Given the considerable heterogeneity, we used a descriptive method instead of statistical synthesis. The median relative rates (RRs) and their interquartile ranges were used to estimate the magnitude of benefit. Compared to conservatively treated MG patients, thymectomized patients had higher survival, clinical remission, pharmacologic remission and improvement rates, and RRs were 1.07 (1.01–1.17), 1.83 (0.82–2.99), 1.55 (1.22–1.95) and 1 (1.00–1.09), respectively. Subgroup analyses showed that patients with moderate to severe generalized MG benefited more from thymectomy, with RRs of survival and pharmacologic remission increasing to 1.35 (1.24–1.49) and 2.68 (1.73–4.17), respectively. These results suggested that thymectomy might be an effective procedure in non-thymomatous MG patients. The patients with moderate to severe generalized MG might benefit more. Taking into account the poor methodological quality of present studies, more well-designed prospective randomized controlled trials (RCTs) are still required to reach unequivocal conclusion.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Zeldowicz LR, Saxton GD. Myasthenia gravis: comparative evaluation of medical and surgical treatment. Can Med Assoc J, 1969,101(10):88–93

    CAS  PubMed Central  PubMed  Google Scholar 

  2. Emeryk B, Strugalska MH. Evaluation of results of thymectomy in myasthenia gravis. J Neurol, 1976,211(2):155–168

    Article  CAS  PubMed  Google Scholar 

  3. Gronseth GS, Barohn RJ. Practice parameter: thymectomy for autoimmune myasthenia gravis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology, 2000,55(1):7–15

    Article  CAS  PubMed  Google Scholar 

  4. Oosterhuis HJ. Observations of the natural history of myasthenia gravis and the effect of thymectomy. Ann N Y Acad Sci, 1981,377:678–690

    Article  CAS  PubMed  Google Scholar 

  5. Scadding GK, Havard CW, Lange MJ, et al. The long term experience of thymectomy for myasthenia gravis. J Neurol Neurosurg Psychiatry, 1985,48(5):401–406

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  6. Warmolts JR, Engel WK. Benefit from alternate-day prednisone in myasthenia gravis. N Engl J Med, 1972, 286(1):17–20

    Article  CAS  PubMed  Google Scholar 

  7. Grob D, Brunner NG, Namba T. The natural course of myasthenia gravis and effect of therapeutic measures. Ann N Y Acad Sci, 1981,377:652–669

    Article  CAS  PubMed  Google Scholar 

  8. Grob D, Arsura EL, Brunner NG, et al. The course of myasthenia gravis and therapies affecting outcome. Ann N Y Acad Sci, 1987,505:472–499

    Article  CAS  PubMed  Google Scholar 

  9. Christensen PB, Jensen TS, Tsiropoulos I, et al. Mortality and survival in myasthenia gravis: a Danish population based study. J Neurol Neurosurg Psychiatry, 1998, 64(1):78–83

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  10. Mantegazza R, Beghi E, Pareyson D, et al. A multicentre follow-up study of 1152 patients with myasthenia gravis in Italy. J Neurol, 1990,237(6):339–344

    Article  CAS  PubMed  Google Scholar 

  11. Beghi E, Antozzi C, Batocchi AP, et al. Prognosis of myasthenia gravis: a multicenter follow-up study of 844 patients. J Neurol Sci, 1991,106(2):213–220

    Article  CAS  PubMed  Google Scholar 

  12. Jaretzki A, Barohn RJ, Ernstoff RM, et al. Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Ann Thorac Surg, 2000,70(1):327–334

    Article  PubMed  Google Scholar 

  13. Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health, 1998, 52(6):377–384

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  14. Cochrane Handbook for Systematic Reviews of Interventions Version 4. 2.6 [updated September 2006]: The Cochrane Collaboration; 2006. Available from: www.cochrane.org/sites/default/files/uploads/Handbook4.2.6Sep2006.pdf

  15. Mantegazza R, Baggi F, Antozzi C, et al. Myasthenia gravis (MG): epidemiological data and prognostic factors. Ann N Y Acad Sci, 2003,998:413–423

    Article  PubMed  Google Scholar 

  16. Cosi V, Romani A, Lombardi M, et al. Prognosis of myasthenia gravis: a retrospective study of 380 patients. J Neurol, 1997,244(9):548–555

    Article  CAS  PubMed  Google Scholar 

  17. Valli G, Jann S, Premoselli S, et al. Myasthenia gravis treatment: twelve years experience on 110 patients. Ital J Neurol Sci, 1987,8(6):593–601

    Article  CAS  PubMed  Google Scholar 

  18. Wu WX, Wang N. Thymectomy for myasthenia gravis patients and related factors of efficacy. 2011

    Google Scholar 

  19. Bachmann K, Burkhardt D, Schreiter I, et al. Thymectomy is more effective than conservative treatment for myasthenia gravis regarding outcome and clinical improvement. Surgery, 2009,145(4):392–398

    Article  PubMed  Google Scholar 

  20. Werneck LC, Cunha FM, Scola RH. Myasthenia gravis: a retrospective study comparing thymectomy to conservative treatment. Acta Neurol Scand, 2000,101(1):41–46

    Article  CAS  PubMed  Google Scholar 

  21. Papatestas AE, Genkins G, Kornfeld P, et al. Effects of thymectomy in myasthenia gravis. Ann Surg, 1987, 206(1):79–88

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  22. Pasnoor M, Wolfe GI, Nations S, et al. Clinical findings in MuSK-antibody positive myasthenia gravis: a U.S. experience. Muscle Nerve, 2010,41(3):370–374

    Article  PubMed  Google Scholar 

  23. Al-Moallem MA, Alkali NH, Hakami MA, et al. Myasthenia gravis: presentation and outcome in 104 patients managed in a single institution. Ann Saudi Med, 2008, 28(5):341–345

    Article  PubMed  Google Scholar 

  24. Tsinzerling N, Lefvert AK, Matell G, et al. Myasthenia gravis: a long term follow-up study of Swedish patients with specific reference to thymic histology. J Neurol Neurosurg Psychiatry, 2007,78(10):1109–1112

    Article  PubMed Central  PubMed  Google Scholar 

  25. Kawaguchi N, Kuwabara S, Nemoto Y, et al. Effects of thymectomy on late-onset myasthenia gravis without thymoma. Clin Neurol Neurosurg, 2007, 109(10):858–861

    Article  PubMed  Google Scholar 

  26. Evoli A, Tonali PA, Padua L, et al. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis. Brain, 2003,126 (Pt 10):2304–2311

    Article  Google Scholar 

  27. Robertson NP, Deans J, Compston DA. Myasthenia gravis: a population based epidemiological study in Cambridgeshire, England. J Neurol Neurosurg Psychiatry, 1998,65(4):492–496

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  28. Beekman R, Kuks JB, Oosterhuis HJ. Myasthenia gravis: diagnosis and follow-up of 100 consecutive patients. J Neurol, 1997,244(2):112–118

    Article  CAS  PubMed  Google Scholar 

  29. Seto M, Motomura M, Takeo G, et al. Treatment of myasthenia gravis: a comparison of the natural course and current therapies. Tohoku J Exp Med, 1993,169(1):77–86

    Article  CAS  PubMed  Google Scholar 

  30. Donaldson DH, Ansher M, Horan S, et al. The relationship of age to outcome in myasthenia gravis. Neurology, 1990,40(5):786–790

    Article  CAS  PubMed  Google Scholar 

  31. Guillermo GR, Tellez-Zenteno JF, Weder-Cisneros N, et al. Response of thymectomy: clinical and pathological characteristics among seronegative and seropositive myasthenia gravis patients. Acta Neurol Scand, 2004, 109(3):217–221

    Article  CAS  PubMed  Google Scholar 

  32. Romi F, Aarli JA, Gilhus NE. Seronegative myasthenia gravis: disease severity and prognosis. Eur J Neurol, 2005, 12(6):413–418

    Article  CAS  PubMed  Google Scholar 

  33. Sanders DB, El-Salem K, Massey JM, et al. Clinical aspects of MuSK antibody positive seronegative MG. Neurology, 2003,60(12):1978–1980

    Article  CAS  PubMed  Google Scholar 

  34. Kas J, Kiss D, Simon V, et al. Decade-long experience with surgical therapy of myasthenia gravis: early complications of 324 transsternal thymectomies. Ann Thorac Surg, 2001,72(5):1691–1697

    Article  CAS  PubMed  Google Scholar 

  35. Machens A, Busch C, Emskotter T, et al. Morbidity after transsternal thymectomy for myasthenia gravis: a changing perspective? Thorac Cardiovasc Surg, 1998, 46(1):37–40

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Min Zhang  (张 旻).

Additional information

The authors contributed equally to the work.

This project was supported by grants from the National Nature Science Foundation of China (Nos. 81271406 and 81000537) and Program for New Century Excellent Talents in University of China (No. NCET-09-0394).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Luo, Y., Pan, Dj., Chen, Ff. et al. Effectiveness of thymectomy in non-thymomatous myasthenia gravis: a systematic review. J. Huazhong Univ. Sci. Technol. [Med. Sci.] 34, 942–949 (2014). https://doi.org/10.1007/s11596-014-1378-x

Download citation

  • Received:

  • Revised:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11596-014-1378-x

Key words

Navigation